Biohaven Ltd (BHVN)

$14.94 -0.67 (-4.29%)
Market Cap 1.65B
Revenue (ttm) 0.00
Net Income (ttm) -846.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.91
Volume 2,398,000
Avg Vol 2,007,060
Day's Range N/A - N/A
Shares Out 105.79M
Stochastic %K 56%
Beta 0.98
Analysts Strong Sell
Price Target $46.71

Company Profile

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment of neurological and neuropsychiatric illnesses; taldefgrobep alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 3 clinical trial for the treatment of focal and generalized epilepsy, and major depressive disorder; BHV-2100 tha...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 404 0410
Address:
215 Church Street, New Haven, United States
Kelticsterling
Kelticsterling Aug. 26 at 12:01 PM
$BHVN kind of funny August 11 prospectus is already preparing for Launch
0 · Reply
Reneejordan001
Reneejordan001 Aug. 25 at 8:27 PM
$BHVN Please elaborate on why they would get a CRL? There are no serious adverse events that occurred. 👇
0 · Reply
Kevoo
Kevoo Aug. 25 at 2:21 PM
$BHVN CRL most likely in 2 weeks
1 · Reply
JJBurch
JJBurch Aug. 25 at 1:34 PM
$BHVN $IXHL $TNFA Remember me
1 · Reply
Reneejordan001
Reneejordan001 Aug. 25 at 1:11 PM
$BHVN Huh? Who tf is burning through 2M a day?
0 · Reply
Reneejordan001
Reneejordan001 Aug. 25 at 12:12 PM
$BHVN It would be seriously remiss of the FDA not approving this drug for SCA. It would be the only one approved thus far if they do 🤞🙏
0 · Reply
HamBoneXoXo
HamBoneXoXo Aug. 25 at 9:33 AM
$BHVN Just over 700 mil annual burn or about $2 mil per day. Is that correct? If yes, I say that’s crazy.
0 · Reply
BatteryBaron
BatteryBaron Aug. 23 at 7:27 AM
$BHVN Biohaven Ltd is a neuroscience company with approved migraine drug facing competition
1 · Reply
BiotechBonesaw
BiotechBonesaw Aug. 22 at 11:38 PM
$BHVN 🐂 quite
0 · Reply
Lastcall
Lastcall Aug. 22 at 10:52 PM
$BHVN Them big sell orders sure as hell looked like an ATM
0 · Reply
Latest News on BHVN
Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025

Aug 25, 2025, 8:00 AM EDT - 1 day ago

Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Aug 22, 2025, 10:05 AM EDT - 4 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN

Aug 13, 2025, 4:35 PM EDT - 12 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

Aug 11, 2025, 7:00 AM EDT - 15 days ago

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN

Aug 4, 2025, 8:45 AM EDT - 22 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Jul 29, 2025, 10:22 AM EDT - 4 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Law Offices of Frank R. Cruz Encourages Biohaven Ltd.

Jul 18, 2025, 12:06 PM EDT - 5 weeks ago

Law Offices of Frank R. Cruz Encourages Biohaven Ltd.

Law Offices of Howard G. Smith Encourages Biohaven Ltd.

Jul 18, 2025, 12:00 PM EDT - 5 weeks ago

Law Offices of Howard G. Smith Encourages Biohaven Ltd.

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Jul 15, 2025, 10:46 AM EDT - 6 weeks ago

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

Jun 10, 2025, 2:00 PM EDT - 2 months ago

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

May 29, 2025, 7:01 AM EDT - 3 months ago

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)

May 28, 2025, 3:00 PM EDT - 3 months ago

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)

Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors

May 28, 2025, 7:30 AM EDT - 3 months ago

Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors

Why Is Biohaven Stock Falling On Thursday?

May 15, 2025, 1:22 PM EDT - 3 months ago

Why Is Biohaven Stock Falling On Thursday?

FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

May 14, 2025, 6:43 PM EDT - 3 months ago

FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments

May 12, 2025, 4:05 PM EDT - 3 months ago

Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments

Biohaven Is Now A Compelling Contrarian Play Before Troriluzole's FDA Verdict

May 5, 2025, 8:00 AM EDT - 4 months ago

Biohaven Is Now A Compelling Contrarian Play Before Troriluzole's FDA Verdict

Biohaven Announces Investment up to $600 Million by Oberland Capital

Apr 28, 2025, 7:30 AM EDT - 4 months ago

Biohaven Announces Investment up to $600 Million by Oberland Capital

BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm

Apr 15, 2025, 9:10 AM EDT - 4 months ago

BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm

Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting

Apr 5, 2025, 9:00 AM EDT - 5 months ago

Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting

Biotech stocks have been hit hard. Why they're a great value now.

Mar 27, 2025, 7:40 AM EDT - 5 months ago

Biotech stocks have been hit hard. Why they're a great value now.

PFE DNLI GPCR INSM MRK SWTX

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Bronstein, Gewirtz & Grossman, LLC (BHVN) and Encourages Stockholders to Learn More About the Investigation

Mar 20, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Bronstein, Gewirtz & Grossman, LLC (BHVN) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Shareholders to Learn More About the Investigation

Mar 19, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Shareholders to Learn More About the Investigation

Kelticsterling
Kelticsterling Aug. 26 at 12:01 PM
$BHVN kind of funny August 11 prospectus is already preparing for Launch
0 · Reply
Reneejordan001
Reneejordan001 Aug. 25 at 8:27 PM
$BHVN Please elaborate on why they would get a CRL? There are no serious adverse events that occurred. 👇
0 · Reply
Kevoo
Kevoo Aug. 25 at 2:21 PM
$BHVN CRL most likely in 2 weeks
1 · Reply
JJBurch
JJBurch Aug. 25 at 1:34 PM
$BHVN $IXHL $TNFA Remember me
1 · Reply
Reneejordan001
Reneejordan001 Aug. 25 at 1:11 PM
$BHVN Huh? Who tf is burning through 2M a day?
0 · Reply
Reneejordan001
Reneejordan001 Aug. 25 at 12:12 PM
$BHVN It would be seriously remiss of the FDA not approving this drug for SCA. It would be the only one approved thus far if they do 🤞🙏
0 · Reply
HamBoneXoXo
HamBoneXoXo Aug. 25 at 9:33 AM
$BHVN Just over 700 mil annual burn or about $2 mil per day. Is that correct? If yes, I say that’s crazy.
0 · Reply
BatteryBaron
BatteryBaron Aug. 23 at 7:27 AM
$BHVN Biohaven Ltd is a neuroscience company with approved migraine drug facing competition
1 · Reply
BiotechBonesaw
BiotechBonesaw Aug. 22 at 11:38 PM
$BHVN 🐂 quite
0 · Reply
Lastcall
Lastcall Aug. 22 at 10:52 PM
$BHVN Them big sell orders sure as hell looked like an ATM
0 · Reply
TheBiotechInvestor_
TheBiotechInvestor_ Aug. 22 at 9:43 PM
$BHVN My Top 5 Biotech Stocks Set to Explode Before 2026 | FDA Decisions & Data Catalysts Ahead https://youtu.be/AWl1dHkqXHs
0 · Reply
sellthedip1
sellthedip1 Aug. 22 at 8:17 PM
$BHVN the move is we start seeing insider buying
1 · Reply
Dragonfire89
Dragonfire89 Aug. 22 at 8:05 PM
$BHVN I’m hoping this ADCOM cancellation is a good thing. In June, CAPR had the same thing happen and about two weeks later a CRL… What do you guys think? Statistically, 2/3 get approved after a ADCOM cancel. I think it will be approved . Hopefully, we don’t hear anything for a while.
2 · Reply
sellthedip1
sellthedip1 Aug. 22 at 4:21 PM
$BHVN new…
0 · Reply
RideDaLightning
RideDaLightning Aug. 22 at 4:11 PM
$BHVN two things we can discern from this guys post. 1. He started a new position 2. This thing is about to moon shot let’s friggin gooooooo
0 · Reply
Dheeraj_6
Dheeraj_6 Aug. 22 at 2:50 PM
$BHVN This is a good news, Don't know why people are selling, this will be at $30 after approval.
2 · Reply
JJBurch
JJBurch Aug. 22 at 2:04 PM
$TNFA .14-.15+++ NEXT WEEK (**guaranteed play) $IXHL $1++ next week absolutely likely $BHVN $20++ next week a LOCK Let’s refer back to this and count how much money we made together
0 · Reply
sellthedip1
sellthedip1 Aug. 22 at 2:01 PM
$BHVN
0 · Reply
JJBurch
JJBurch Aug. 22 at 1:55 PM
$BHVN $IXHL $TNFA HAVE YOU SEEN A TRIPLE BOOM BEFORE??? THESE THREE ARE ENTERING TEIPLE BOOM STATUS LETS PARTY!!!
0 · Reply
JJBurch
JJBurch Aug. 22 at 1:53 PM
$BHVN $IXHL $TNFA It begins NOW!!! Congrats all. Hope you’re loading up with me for these runs!!!
0 · Reply
JJBurch
JJBurch Aug. 22 at 1:45 PM
$BHVN $IXHL $TNFA All of these have consolidated and bottomed and are going to rocket All of them With $TNFA from .062 to .14++ within days Congrats to all who follow!!! 🙏 🎉
0 · Reply
topstockalerts
topstockalerts Aug. 22 at 1:35 PM
$BHVN this setup continues to provide opportunities.. stay tuned!
0 · Reply